EQ Equillium, Inc.
Healthcare$2.32+2.65%ClosedMarket Cap: $82.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.66
P/S
0.00
EV/EBITDA
-0.97
DCF Value
$0.32
FCF Yield
-23.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-61.4%
ROA
-30.2%
ROIC
-33.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-5.6M | $-5.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-4.0M | $-3.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-23.6M | $-22.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.6M | $-4.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-6.2M | $-5.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-8.9M | $-8.7M | $— | — |
| Q4 null | $4.4M | 100.0% | $-4.7M | $-5.8M | $— | — |
| FY null | $41.1M | 100.0% | $-8.3M | $-8.1M | $— | — |
| Q3 null | $12.2M | 100.0% | $-679.0K | $-7.0K | $— | — |
| Q2 null | $13.9M | 100.0% | $-100.0K | $468.0K | $— | — |
| Q1 null | $10.7M | 99.7% | $-2.8M | $-2.7M | $— | — |
| Q4 2023 | $9.2M | 99.6% | $-3.2M | $-2.3M | $-0.07 | — |